Dobutamine ( DrugBank: Dobutamine )

3 diseases

ID	Disease name (Link within this page)	Number of trials
57	Idiopathic dilated cardiomyopathy	1
58	Hypertrophic cardiomyopathy	2
215	Tetralogy of Fallot	2

57. Idiopathic dilated cardiomyopathy

Clinical trials : 12 / Drugs : 25 - (DrugBank : 12) / Drug target genes : 9 - Drug target pathways : 34

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00281255 (ClinicalTrials.gov)	June 2003	20/1/2006	Intravenous Allopurinol to Improve Heart Function in Individuals With Dilated Cardiomyopathy	Allopurinol and Cardiac Function Pilot Study in Idiopathic Dilated Cardiomyopathy	Cardiovascular Diseases;Cardiomyopathy, Dilated;Heart Diseases;Heart Failure, Congestive	Drug: Allopurinol;Drug: Dobutamine	University of Pennsylvania	National Heart, Lung, and Blood Institute (NHLBI)	Withdrawn	18 Years	N/A	Both	0	Phase 1/Phase 2	United States

Clinical trials : 119 / Drugs : 163 - (DrugBank : 45) / Drug target genes : 48 - Drug target pathways : 161

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05025644 (ClinicalTrials.gov)	August 2021	11/8/2021	Quantitative Assessment of Hypertrophic Obstructive Cardiomyopathy With Intraoperative Three-dimensional Transesophageal Echocardiography Under Provocative Dobutamine Stress Test	Quantitative Assessment of Hypertrophic Obstructive Cardiomyopathy With Intraoperative Three-dimensional Transesophageal Echocardiography Under Provocative Dobutamine Stress Test	Hypertrophic Obstructive Cardiomyopathy	Drug: Pre and post-CPB Drug: Dobutamine Hydrochloride;Drug: Post-CPB Drug: Dobutamine Hydrochloride	University Health Network, Toronto	NULL	Not yet recruiting	18 Years	N/A	All	60	Phase 4	NULL
2	NCT01375335 (ClinicalTrials.gov)	June 2011	14/6/2011	The Effects of Dobutamine on Postoperative Cardiac Function in Aortic Valve Replacement	The Effects of Dobutamine on Postoperative Systolic Deformation and Diastolic Function in Patients With Hypertrophic Cardiomyopathy Operated for Aortic Valve Stenosis	Heart Failure	Drug: Dobutamine	University of Aarhus	NULL	Suspended	19 Years	90 Years	Both	10	Phase 4	Denmark

Clinical trials : 22 / Drugs : 48 - (DrugBank : 19) / Drug target genes : 18 - Drug target pathways : 49

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2007-003461-41-DE (EUCTR)	13/11/2007	10/09/2007	Cardiac imaging under dobutamine stress for early assessment of right ventricular function in patients with tetralogy of Fallot and pulmonary regurgitation - Fallot-stress	Cardiac imaging under dobutamine stress for early assessment of right ventricular function in patients with tetralogy of Fallot and pulmonary regurgitation - Fallot-stress	Fallot tetralogy late after repair with marked pulmonary valve incompetence	INN or Proposed INN: Dobutamine	Deutsche Herzzentrum Berlin, Kompetenznetz Angeborene Herzfehler	NULL	Not Recruiting			Female: yes Male: yes	80		Germany
2	NCT00557934 (ClinicalTrials.gov)	October 2007	13/11/2007	Right Ventricular Contractility Reserve Following Repair of Tetralogy of Fallot	Evaluation of Right Ventricular Contractility Reserve Function During Dobutamine Stress in Patients Following Surgical Repair of Tetralogy of Fallot	Right Ventricular Dysfunction	Other: dobutamine	University Hospital Tuebingen	Fördergemeinschaft Deutsche Kinderherzzentren, Bonn, Germany	Completed	4 Years	N/A	Both	16	N/A	Germany